Soligenix
SNGX
#10224
Rank
โ‚น1.46 B
Marketcap
โ‚น145.05
Share price
-1.23%
Change (1 day)
-50.91%
Change (1 year)

Soligenix (SNGX) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚น34.69 Million

According to Soligenix's latest financial reports the company's total debt is โ‚น34.69 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Soligenix - Total debt on balance sheet (from 1998 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚น0.12 B-56.22%
2023-12-31โ‚น0.29 B-65.67%
2022-12-31โ‚น0.84 B14.28%
2021-12-31โ‚น0.74 B-3.49%
2020-12-31โ‚น0.76 B8369.11%
2019-12-31โ‚น9.07 M
2018-12-31N/A
2016-12-31N/A-100%
2015-12-31โ‚น19.45 M-91.9%
2014-12-31โ‚น0.24 B-53.06%
2013-12-31โ‚น0.51 B
2004-12-31โ‚น5.02 M-69.28%
2003-12-31โ‚น16.34 M-53.3%
2002-12-31โ‚น35 M234.56%
2001-12-31โ‚น10.46 M-30.58%
2000-12-31โ‚น15.07 M-11.61%
1999-12-31โ‚น17.05 M0.26%
1998-12-31โ‚น17 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น59.74 B 172,109.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น2.300 T 6,630,476.49%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
โ‚น5.482 T 15,802,358.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น4.125 T 11,893,037.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚น1.67 B 4,724.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น1.538 T 4,433,823.55%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel